GEOapplication/xmlftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE325nnn/GSE325008/primaryOK200TranscriptomicsHomo sapiensExpression profiling by arrayhttps://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE325008GEOGSEfalseTargeting UHRF1: An Ixazomib Citrate Analogue as a Promising Therapeutic Agent for KRAS-Mutant Pancreatic CancerTo investigate the effect of Ixazomib Citrate Analogue (ICA) inKRAS mutant on gene expression, we have emoloyed whole genomic microarray expression profiling using cancer cells2026/05/30GSE325008GSM9590864GSM9590862GSM9590863GSM9590860GSM9590861GSM959085916699325008Homo sapiens